The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
UKOF 2018 | Future prospects for treating rectal cancer
Kai-Keen Shiu, MRCP, PhD, of University College London Hospitals NHS Foundation Trust, London, UK, speaks to us about future directions for the treatment of rectal cancer at the UK Oncology Forum (OF) 2018, held in Liverpool, UK. He discusses the possibility of a new treatment strategy using total neoadjuvant therapy with reduced oxaliplatin dosage, as well as the prospect of using circulating tumor (ct)DNA in an adjuvant setting to identify patient prognoses. Dr Shiu emphasises the need for more clinical trials in this field, in order to properly care for patients using these new tools.
